This review covers COPD burden, GOLD guidelines and where aclidinium/eformoterol fits into current practice together with some key evidence and discussion around its use.
Commentary has been provided by Dr Christopher Worsnop, a respiratory and sleep physician at the Austin and Northern Hospitals in Melbourne.
Please login below to download this issue (PDF)